Francesco Papaleo Selected Research

Francesco Papaleo Research Topics

Disease

19	Schizophrenia (Dementia Praecox) 10/2022 - 11/2009
7	Psychotic Disorders (Schizoaffective Disorder) 06/2021 - 08/2008
6	Mental Disorders (Mental Disorder) 10/2019 - 08/2011
3	Neurobehavioral Manifestations 01/2022 - 04/2014
2	Cognitive Dysfunction 01/2022 - 11/2020
2	Autism Spectrum Disorder 10/2020 - 01/2018
2	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2020 - 10/2016
2	AIDS-Related Complex (ARC) 01/2017 - 01/2016
2	Tremor (Tremors) 11/2008 - 06/2006
2	Substance-Related Disorders (Drug Abuse) 11/2008 - 12/2005
2	Opioid-Related Disorders (Opiate Addiction) 11/2008 - 12/2005
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2008 - 06/2006
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2021
1	Rare Diseases (Rare Disease) 01/2020
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2020
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Brain Diseases (Brain Disorder) 05/2018
1	Central Nervous System Diseases (CNS Diseases) 05/2018
1	Autistic Disorder (Autism) 04/2014
1	Alcoholism (Alcohol Abuse) 09/2012
1	Nervous System Diseases (Neurological Disorders) 05/2012
1	Seizures (Absence Seizure) 08/2011
1	Memory Disorders (Memory Loss) 08/2008
1	Pain (Aches) 08/2008
1	Heroin Dependence (Heroin Abuse) 12/2005

Drug/Important Bio-Agent (IBA)

7	Dopamine (Intropin)FDA LinkGeneric 10/2022 - 08/2008
7	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2014
6	DysbindinIBA 01/2022 - 11/2009
6	Pharmaceutical PreparationsIBA 12/2020 - 11/2008
4	Amphetamine (Amfetamine)FDA LinkGeneric 10/2019 - 08/2008
3	Protein Isoforms (Isoforms)IBA 10/2022 - 01/2016
3	Biological ProductsIBA 01/2017 - 07/2012
3	Opiate AlkaloidsIBA 11/2008 - 12/2005
2	Dihydroxyphenylalanine (Dopa)IBA 06/2021 - 05/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2013
2	Neuregulin-1 (Neuregulin 1)IBA 01/2016 - 07/2012
2	NeuregulinsIBA 07/2012 - 03/2012
2	Corticotropin-Releasing HormoneIBA 11/2008 - 12/2005
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	Paroxetine (Paxil)FDA LinkGeneric 05/2021
1	Retinaldehyde (Retinal)IBA 01/2020
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2018
1	Potassium Channels (Potassium Channel)IBA 11/2016
1	Ether (Diethyl Ether)IBA 11/2016
1	Polytetrafluoroethylene (Teflon)FDA Link 10/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2016
1	Nerve Growth Factors (Neurotrophins)IBA 01/2016
1	VDR interacting protein complex DRIPIBA 01/2016
1	Oxytocin (Pitocin)FDA LinkGeneric 04/2014
1	Illicit Drugs (Recreational Drugs)IBA 09/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2012
1	phosphoinositide-3,4,5-triphosphateIBA 07/2012
1	IC 87114IBA 07/2012
1	triphosphoric acid (triphosphate)IBA 07/2012
1	Proline Oxidase (Proline Dehydrogenase)IBA 03/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2011
1	Glutamic Acid (Glutamate)FDA Link 01/2011
1	Naloxone (Narcan)FDA LinkGeneric 11/2008
1	Morphine (MS Contin)FDA LinkGeneric 11/2008
1	EnzymesIBA 08/2008
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 08/2008
1	CRF receptor type 1IBA 12/2005

Therapy/Procedure

4	Therapeutics 10/2020 - 11/2008
1	Precision Medicine 11/2020
1	Immunomodulation 10/2019
1	Intranasal Administration 04/2014